Core Insights - IQVIA Holdings Analytics Inc. reported strong third-quarter 2025 results, with earnings and revenues exceeding the Zacks Consensus Estimate [1][9] - Adjusted earnings were $3 per share, a 5.6% increase year-over-year, while total revenues reached $4.1 billion, reflecting a 5.2% growth from the previous year [1][9] Financial Performance - The Research and Development segment generated revenues of $2.3 billion, up 4.5% year-over-year, surpassing the estimate of $2.2 billion [3] - Technology and Analytics segment revenues were $1.6 billion, growing 5% year-over-year, but fell short of the projected $1.7 billion [3] - Contract Sales and Medical Solutions revenues increased 16.1% year-over-year to $209 million, exceeding the estimate of $181.7 million [4] - Adjusted EBITDA for the quarter was $949 million, a 1.1% rise from the previous year, surpassing the anticipated $945.3 million [4] Cash Flow and Debt - The company ended the quarter with cash and cash equivalents of $1.8 billion, down from $2 billion in the previous quarter [5] - Long-term debt decreased to $15 billion from $15.4 billion at the end of the second quarter [5] - Net cash generated from operating activities was $908 million, with capital expenditures of $136 million, resulting in a free cash flow of $772 million for the quarter [5] 2025 Guidance - IQVIA updated its revenue guidance for 2025 to a range of $16.15-$16.25 billion, with the midpoint exceeding the Zacks Consensus Estimate of $16.16 billion [6] - The earnings per share outlook was revised to $11.85-$11.95, with the midpoint also above the consensus estimate of $11.86 [6] - Adjusted EBITDA guidance was updated to $3.775-$3.800 billion, reflecting a slight increase from the previous quarter's view [7]